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Abstract: The basic-helix-loop-helix transcription factors Ascl1/Mash1, Hes1, and Olig2
regulate fate choice of neurons, astrocytes, and oligodendrocytes, respectively.  These same
factors are coexpressed by neural progenitor cells. Here, we found by time-lapse imaging that
these factors are expressed in an oscillatory manner by mouse neural progenitor cells. In each
differentiation lineage, one of the factors becomes dominant. We used optogenetics to control
expression of Ascl1, and found that although sustained Ascl1 expression promotes neuronal fate
determination, oscillatory Ascl1 expression maintains proliferating neural progenitor cells. Thus,
the multipotent state correlates with oscillatory expression of several fate-determination factors,
whereas the differentiated state correlates with sustained expression of a single factor.
Word limit includes text + references + figure and table legends
2Main Text: Analyses of populations of mouse hematopoietic progenitors suggest that general
fluctuations in the transcriptome affect lineage choice (1).  On the other hand, analyses of
individual cells do not show an effect of transcriptome fluctuation on lineage choice (2). Fate
choice could be a gradual process based on transcriptome-wide fluctuations or discrete processes
through different subpopulation states, To address these issues, we study the expression patterns
of fate determination factors in individual mouse cells in the multipotent state and during fate
choice processes.
In the developing murine nervous system, neural progenitor cells (NPCs) proliferate
(reproducing themselves) and also differentiate into three cell types, neurons, oligodendrocytes,
and astrocytes (thus demonstrating multipotency). Transcription factors that regulate the
proliferation of NPCs and the differentiation of each cell type include basic helix-loop-helix
(bHLH) transcription factors (3,4). For example, proneural bHLH genes such as Ascl1/Mash1
and Neurogenin2 (Ngn2) promote neuronal fate determination and suppress astrocytic gene
expression (5-7). The bHLH gene Olig2 regulates oligodendrocyte specification, while the
bHLH genes Hes1 and Hes5 maintain NPCs by repressing proneural gene expression (8-12).
Ascl1 and Olig2 also regulate oligodendrocyte and motor neuron development, respectively (8-
10,13-18). One model suggests that Hes genes, expressed by NPCs, repress expression of other
bHLH genes; down-regulation of Hes genes allows up-regulation of proneural genes or Olig2
and subsequent differentiation into neurons or oligodendrocytes (4). However, Ascl1 is expressed
by dividing NPCs and postmitotic neurons, and Ascl1 up-regulates the expression of genes
involved in cell cycle progression of NPCs as well as in cell cycle exit and neuronal
differentiation (19,20). Furthermore, Hes1 promotes the maintenance of NPCs and astrocyte
differentiation (11,12,21,22). Olig2 is also involved in NPC proliferation (23). Thus, these bHLH
genes exert contradictory functions.
Hes1 expression oscillates with a period of approximately 2-3 hours in many cell types
including NPCs (24,25). Ngn2 expression also oscillates in NPCs probably because it is
periodically repressed by Hes1 oscillation. In differentiating neurons, which lack Hes1
expression, Ngn2 expression is steady (25). Thus, the pattern of bHLH gene expression differs
between NPCs and neurons, although our previous time-lapse imaging study only monitored
mRNA production (25). As transcription and translation can be dissociated (26), we here study
protein expression at the single cell level. We found that Hes1, Ascl1, and Olig2 protein
expression oscillates in NPCs.
Variable levels of bHLH transcription factor expression in NPCs
Ascl1, Hes1, and Olig2 are expressed by NPCs in the ventral telencephalon, which generate
neurons, astrocytes, and oligodendrocytes during perinatal stages of mouse development (14-
18,27,28). The expression levels of these transcription factors were variable from cell to cell (Fig.
1A-H).  Many cells were positive for all three bHLH factors (Hes1, Ascl1, and Olig2), while
others expressed only two (Fig. 1E-H). By contrast, differentiating neurons, oligodendrocytes,
and astrocytes expressed only one of them at later stages (i.e., Ascl1, Olig2, and Hes1,
respectively)(18,22,29). To examine the expression of these bHLH factors, we generated
transgenic mice carrying reporters in which fluorescent (Venus or mCherry) or firefly luciferase
(Luc2) cDNA was inserted in frame into the 5' region of each bHLH gene in BAC clones so that
a bHLH factor fused with either Venus, mCherry, or Luc2 was expressed (table S1, fig. S1A-F).
We also generated knock-in mice in which Venus was inserted in frame into the 5' region of the
Hes1 gene for Hes1 imaging (table S1, fig. S2A), those in which Venus or luciferase (Eluc) was
3inserted in frame into the 5' region of the Hes5 gene for Hes5 imaging (table S1, fig. S2B,C), and
Sox2 reporter mice expressing a Luc2-Sox2 fusion protein (table S1, fig. S1G). The reporter
expression in these mice was similar to endogenous expression (fig. S3). Reporter expression
also correlated well with endogenous protein expression in NPCs (fig. S4). The brain structures
and the NPC competency of these reporter mice including homozygous Venus-Hes1 fusion
knock-in mice were apparently normal (fig. S5).
We used time-lapse imaging of brain slices from the ventral telencephalon of reporter
mice and found that Hes1 and Ascl1 expression oscillate in NPCs (Fig. 1I-K, movie S1).
Oscillatory expression of bHLH factors in NPCs
We next prepared NPCs from the ventral telencephalon of perinatal reporter mice. We used
acutely dissociated NPCs and those maintained in vitro for at least ten generations in the
presence of EGF and bFGF (NS cells)(30,31). Both cell types exhibited similar expression
oscillations in the progenitor state and during cell fate choice. These NPCs express Ascl1, Olig2,
and Hes1 at variable levels (fig. S6) and generate GABAergic neurons, oligodendrocytes, and
astrocytes (fig. S7, (14)). Their competency to generate neurons and oligodendrocytes was
significantly reduced in the absence of Ascl1 and Olig2, respectively (fig. S7G,H’’,I,K). These
NPCs also showed a reduced ability to generate astrocytes in the absence of Hes1 (fig. S7F’,J).
Compared to the bHLH factors, the NPC-specific factor Sox2 (32) was expressed at a relatively
constant level (fig. S6A,E,J).
We used time-lapse imaging to analyze expression patterns of bHLH factors. Hes1
protein expression oscillated in NPCs (average period 149.9 ± 12.3 min)(Fig. 2A,D,G,H, fig. S8,
movie S2). Hes5 expression in NPCs oscillated in phase with Hes1 expression (figs. S9 and S10).
Ascl1 expression oscillated in NPCs (average period 175.4 ± 29.5 min)(Fig. 2B,E,G,I, fig. S11,
movie S3). The Ascl1 protein level was up-regulated during S/G2 in some cells (~30%, fig.
S11C,D); after cell division both daughter cells showed equal amounts of Ascl1, and expression
oscillations resumed in cells that remained undifferentiated (fig. S11D). Olig2 protein expression
also oscillated, but more slowly (average period 375.5 ± 105.8 min) than Hes1 and Ascl1 protein
oscillations (Fig. 2C,F,G, fig. S12, movie S4). The average expression levels of these factors are
different between G1 and S/G2/M (fig. S13), although their expression oscillated throughout the
cell cycle. By contrast, two other factors characteristic of NPCs were expressed steadily: Sox2
and Nestin (figs. S13C and S14, movie S5). Hes1 and Ascl1 expression are inversely correlated
(fig. S15A,D, (33)); Hes1 represses Ascl1 expression by binding to the Ascl1 promoter (34).
Oscillating Hes1 would periodically repress Ascl1 expression, thereby driving oscillations in
Ascl1 expression. Indeed, oscillatory Ascl1 expression was lost in the absence of Hes1 (fig.
S11E,F). Expression of Olig2, on the other hand, changes independently of Ascl1 and Hes1 (fig.
S15B,C,E,F).
We next examined whether the oscillations in bHLH factor expression levels create a
bias in differentiation competency. We separated NPCs of the fluorescent reporter mice into
Hes1-high, Hes1-low, Ascl1-high, Ascl1-low, Olig2-high, and Olig2-low fractions (fig. S16A-C).
All cell fractions kept in NS media returned to original diverse levels of Hes1, Ascl1, and Olig2
expression within 2 days, suggesting that diverse levels represent different phases of expression
oscillation (fig. S16D-L). All cells generated neurospheres at similar efficiencies (fig. S16M-R).
After sorting, each cell population was cultured in a differentiation medium. Hes1-high and
Hes1–low cells preferentially differentiated into astrocytes and neurons, respectively (fig.
S17A,B). Ascl1-high (and Olig-2 low) and Olig2-high (and Ascl1-low) cells preferentially
4differentiated into neurons and oligodendrocytes, respectively (fig. S17A,C-G). These results
suggest that the different expression levels of the bHLH factors bias the fate choice of NPCs.
However, such transient high expression is neither required nor sufficient for cell fate
determination: NPCs with high expression of any of Ascl1, Olig2, and Hes1 were all able to
differentiate into any of the three cell types (fig. S17).
Sustained expression of bHLH factors during cell fate choice
We next examined how the expression of these bHLH factors changes during cell fate choice.
During neuronal differentiation, Ascl1 protein accumulated after cell division (Fig. 3A-D), in
contrast to oscillatory expression in NPCs, and 6-8 hours later, the early neuronal marker
Doublecortin (DCX) was expressed (Fig. 3A,C-D’). Ascl1 expression continued to be up-
regulated in many cells (76.7%, Fig. 3A-C) but not in others (23.3%, Fig. 3D) after DCX
expression was initiated, raising the possibility that the minimum requirement for neuronal
differentiation is accumulation of Ascl1 over 6 to 8 hours during G1.
In acute dissociation culture from the ventral telencephalon, many NPCs underwent
asymmetric cell division in which one daughter cell remained undifferentiated while the other
differentiated into a neuron. In these NPCs, Ascl1 expression was up-regulated (at least two-fold
compared to the average) before cell division and seemed to be equally distributed in both
daughter cells (Fig. 3E). In the daughter neuron, Ascl1 expression accumulated after cell division,
while it resumed oscillating in the daughter NPC (Fig. 3E). Before neurogenic cell division (one
or both daughter cells underwent neuronal differentiation), Ascl1 expression was transiently up-
regulated (at least two-fold compared to the average) in many cases: ~90% of their mother cells
exhibited such transient up-regulation of Ascl1 before cell division (fig. S18B). However, ~30%
of mother cells did so when they produced two daughter NPCs (figs. S11C,D and S18B). Thus,
the transient up-regulation of Ascl1 before cell division is not decisive, but merely lends a bias
toward neuronal fate choice.
In those NPCs whose daughter cells underwent neuronal differentiation, Hes1
expression was repressed before cell division (Fig. 3E’, fig. S18A,E,F) but not when both cells
remained NPCs (fig. S18A,C,D). The suppression of Hes1 expression was maintained in
daughter neurons (Fig. 3E’, fig. S18E,F), while Hes1 oscillation resumed in daughter NPCs (Fig.
3E’). Thus, it is likely that transient down-regulation of Hes1 expression and the concomitant up-
regulation of Ascl1 before cell division directs NPCs toward neuronal fate choice, and that
sustained expression of Ascl1 after cell division irreversibly determines neuronal fate. Down-
regulation of Hes1 could be caused by fluctuations of the expression levels of Notch intracellular
domain (NICD), an active form of Notch signaling (35)(fig. S19). Indeed, when stable NICD
expression was induced from the Rosa26 locus in NPCs, both Hes1 and Hes5 expression
oscillated sustainably, and there was no down-regulation of these factors (figs. S20 and S21). By
contrast, in the presence of a γ–secretase inhibitor, which inhibits Notch signaling activity, Ascl1
and Olig2 expression was up-regulated to stable expression (fig. S22).
During astrocyte differentiation, Hes1 protein expression still oscillated but at high
average and trough levels (Fig. 4A,B, fig. S23B,C). 12-24 hours later, expression of the astrocyte
marker GFAP began (fig. S23A). Ascl1 and Olig2 expression became undetectable within 10
hours during astrocyte differentiation (fig. S23D-G). During oligodendrocyte differentiation,
Olig2 protein expression oscillated, but at high trough levels (Fig. 4C,D, fig. S24A,C,E). A few
days after induction of oligodendrocyte differentiation, Olig2 expression was down-regulated,
and expression of the mature oligodendrocyte marker 2',3'-Cyclic-nucleotide-3'-
5phosphodiesterase (CNPase)(fig. S25) was up-regulated (Fig. 4E, fig. S24B,D,G). During this
period, Ascl1 and Hes1 expression were down-regulated (fig. S24H-J). Thus, bHLH fate
determination factors are coexpressed in an oscillatory manner in NPCs, but as the cell fate
choice becomes established, one factor accumulates and the other two are lost. Although
oscillatory expression of multiple fate determination factors underlies the multipotent state of
NPCs, this oscillatory pattern gives way to stable and dominant expression of one factor during
cellular differentiation.
Light-induced control of expression pattern
To demonstrate the functional importance of oscillatory or sustained expression patterns, we
adopted the optogenetic gene expression system using the Neurospora crassa photoreceptor
Vivid that was fused with Gal4 DNA-binding domain and p65 activation domain (GAVPO)(36).
The codon usage was optimized for mammalian cells to increase expression efficiency, and the
target mRNA was destabilized by introducing the 3’-untranslated region of mouse Ascl1 mRNA
(fig. S26A). With this system, we can induce gene expression comparable to endogenous levels
(fig. S26D-G). Repeated exposure of blue light with 3-hour intervals generated oscillatory
expression with a 3-hour period, while repeated exposure with 30-min intervals generated
sustained expression at both cell population (Fig. 5A) and single cell levels (Fig. 5B,C, movie
S6).
Because Ascl1 is known to promote the cell cycle progression of NPCs and their cell
cycle exit and neuronal differentiation (20), we asked whether these contradictory functions of
Ascl1 are regulated by different expression patterns. We introduced the Ascl1-inducible system
into Ascl1-null NS cells, which produce no neurons (fig. S7) and proliferate more slowly than
wild-type NS cells (20). Ascl1-null NS cells have a low proportion (4-5%; PH3+) of dividing
cells (Fig. 5E), while wild-type NS cells have 14-15% PH3+ dividing cells (see Fig S29C).
However, light-induced oscillatory expression of Ascl1 increased the proportion of dividing cells
in the Ascl1-null NS cell population to ~10% PH3+ (Fig. 5E-G), suggesting that Ascl1 oscillation
enhanced NPC proliferation. These NS cells did not differentiate into neurons (βIII-tubulin+)
even after 3 days (Fig. 5D). The period of this oscillation is important, because a 6-hour period
did not affect NPC proliferation (fig. S27). By contrast, light-induced sustained expression of
Ascl1 enhanced neuronal differentiation (βIII-tubulin+) of Ascl1-null NS cells (Fig. 5H-K). A
higher level of sustained Ascl1 expression increased the efficiency of neuronal differentiation
(Compare Fig. 5H versus fig. S28E). However, oscillatory Ascl1 expression did not induce
neuronal differentiation even at a higher amplitude (fig. S28A-C) but increased the number of
proliferating NPCs (fig. S28D). By contrast, sustained Ascl1 expression at similar levels
increased neuronal differentiation (fig. S28E). These results indicate that distinct expression
patterns, but not the levels, of Ascl1 are important for a choice between proliferation and
differentiation.
We used the Ascl1-inducible system in wild-type NS cells where endogenous Ascl1
expression oscillates (fig. S29). Oscillatory light stimulation with 3-hour intervals did not affect
the neurogenesis or proliferation of these cells (figs. S29A-I and S30A-D). By contrast, sustained
Ascl1 expression for 72 hours increased neuronal formation even in the presence of bFGF and
EGF, a condition that inhibits neurogenesis (figs. S29J-Q and S30E). At least 6-to-8 hours of
sustained Ascl1 expression was required for generation of neurons (Fig. 5L-P), agreeing with the
above notion about the minimal requirement for neuronal differentiation. This requirement for
elapsed time suggests that only NS cells that caught at early G1 could be redirected by light-
6induced expression of Ascl1 into neuronal development. The Ascl1-inducible system was also
introduced into the dorsal telencephalon, which normally expresses very low levels of Ascl1. The
oscillatory expression of Ascl1 did not induce neuronal differentiation but did maintain Nestin+
NPCs in the ventricular zone, while the sustained expression of Ascl1 increased the number of
βIII-tubulin+ neurons that migrated out of the ventricular zone (fig. S31). Thus, manipulation of
Ascl1 gene expression can impose a choice favoring proliferation or differentiation according to
whether the Ascl1 expression is oscillatory or sustained.
Discussion
Our data suggest that multipotency is a state of multiple oscillating neurogenic and gliogenic
determination factors, and that cell fate choice is a process of sustained expression of a single
factor. This switching may be induced by the fluctuations of Notch signaling (Supplementary
Text). The detailed mechanism by which the oscillatory and sustained Ascl1 expression
differentially regulates downstream gene expression remains to be determined. It was reported
that the proneural factor Ngn2 is differentially phosphorylated between NPCs and neurons and
controls the expression of its target genes differently depending on its phosphorylation status
(37). We speculate that the oscillatory and sustained expression of proneural factors could be
involved in different posttranscriptional modulation that is responsible for target gene selectivity.
We also demonstrated that the light-switchable gene expression system offers a new way to
control the proliferation and differentiation of stem cells by changing the light exposure pattern
rather than using different growth factors or chemicals, showing its applicability to the
regeneration technology.
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8FIGURES
Fig. 1. Variable expression levels of bHLH factors in NPCs of the ventral telencephalon. (A-H)
The expression of Hes1, Ascl1, and Olig2 in the ventral telencephalon at perinatal stages was
examined by immunohistochemistry. The boxed region in (D) is enlarged in (E-H). Many cells
were positive for all three bHLH factors (Hes1, Ascl1 and Olig2, arrowheads), while others were
mostly positive for two of them. (I-K) Bioluminescence imaging and quantification of Luc2-
Hes1 (I,J) and Luc2-Ascl1 (K) expression in slice cultures of the ventral telencephalon of
reporter mice. Scale bars, 50µm (A–D,I).
Fig. 2. Oscillatory expression of bHLH factors in self-renewing NPCs derived from the ventral
telencephalon. (A-F) Bioluminescence images and quantification of Luc2-Hes1 (A,D), Luc2-
Ascl1 (B,E), and Luc2-Olig2 (C,F) reporter expression. (G-I) The distribution of the oscillation
periods of Hes1, Ascl1, and Olig2 derived from bioluminescence measurements (n>25 NPCs for
each factor).
Fig. 3. Sustained Ascl1 expression in differentiating neurons. Bioluminescence images of Luc2-
Ascl1 (A,B,C,D,E) and Luc2-Hes1 (E’) expression were quantified. (A,C,C’,D,D’) Ascl1
expression accumulated in differentiating neurons (A, green line; C,D, orange double asterisks).
The early neuronal marker Doublecortin (Dcx) was monitored by DCX-DsRed. Transient up-
regulation of Ascl1 expression occurred before cell division (C,D, magenta asterisks). (B)
Temporal trajectories of Luc2-Ascl1 in NS cells just after NPC or neurogenic division at time =
0 (mean in solid line, and standard errors in colored, n>19 for each division). Division-mode
effect, p=0.0022; interaction between division-mode and time, p<0.0001, repeated measures
ANOVA. (E) This acutely dissociated NPC underwent asymmetric cell division. Ascl1 was
equally distributed in both daughter cells after the first cell division. Ascl1 expression
accumulated in a daughter neuron (green) but resumed oscillating in a daughter NPC (red),
which underwent the second division. (E’) Hes1 expression was repressed before asymmetric
cell division (asterisks). The suppression of Hes1 expression was maintained in a daughter
neuron (blue line), whereas Hes1 oscillation resumed in a daughter NPC (red line).
Fig. 4. Expression dynamics of bHLH factors during gliogenesis. (A,B) Bioluminescence
imaging (A) and quantification (B) of Luc2-Hes1 expression during astrocyte differentiation.
Astrocyte specification was induced at time = 0 by LIF and BMP4. (C-E) Bioluminescence
imaging (C) and quantification (D) of Luc2-Olig2 expression and quantification of pCNP-Venus
(E) in a single cell during oligodendrocyte differentiation, which was induced by T3 at time = 0.
Fig. 5. Light-induced oscillatory/sustained expression of Ascl1 in NPCs. (A-C) Time-lapse
imaging (C) and quantification (A,B) of gene expression at cell population (A) and single cell
levels (B,C) induced by blue light. (D-K) According to the schedule of light exposure (fig.
S26B; light intensity: 1.11µmol/m2/s), oscillatory (D-G) and sustained (H-K) Ascl1 expression
was induced in Ascl1-null NPCs, which were cultured in the presence of bFGF and EGF, a
condition that inhibits neurogenesis. Oscillatory Ascl1 expression induced virtually no βIII-
tubulin+ neuron formation (D) but significantly increased the proportion of dividing cells (PH3+),
compared to the control (Ub-luc2) (E-G). Sustained Ascl1 expression significantly increased
9βIII-tubulin+ neuron formation, compared to the control (Ub-luc2) (H,J,K). *p<0.05, **p<0.01;
two-tailed Student’s t-test. (L-P) According to the schedule of light exposure (fig. S26C),
sustained Ascl1 expression was induced in NPCs for indicated time lengths, and neuronal
formation was examined. *p<0.05, **p<0.01, ***p<0.001, one-way ANOVA followed by Tukey
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Materials and Methods 
 
Plasmid construction  
 To analyze the promoter activity, the ubiquitinated luciferase (Ub-luc) was used as 
a reporter, as previously described (38,39). This luciferase was fused at its N-terminus to 
one copy of a mutant ubiquitin (G76V) that resists cleavage by ubiquitin hydrolases. The 
resultant Ub-Luc is extremely unstable with a half-life of less than 10 min (38,39). The 
optimized firefly luciferase luc2 (Promega) was used for most Ub-luc constructs. For 
two-color simultaneous imaging of two promoter activities in single cells, Eluc from 
Pyrearinus termitilluminans (TOYOBO) and Red luc from Phrixothrix hirtus 
(TOYOBO) were used. For easier single-cell tracking, four copies of nuclear localization 
signal (NLS) of SV40 large T-antigen were attached to Ub-luc. This NLS-Ub-Luc coding 
sequence was inserted into the reporter constructs that contain the 5’-flanking sequences 
and the downstream sequences including the 3’-UTR regions.  
 For the Hes5 reporter construct, 3-kb of the 5’-flanking sequence and 2-kb of 
downstream sequence were used. For the Rosa26 reporter construct, 0.8-kb of the 5’-
flanking sequence of the Rosa26 locus and SV40 late poly-A adenylation sequence were 
used. For the Nestin reporter construct, the 5.8-kb promoter and second intron enhancer 
sequence of Nestin, and SV40 late poly-A adenylation sequence were used. For the 
RBPjk-activity reporter construct, four tandem copies of the RBPjk-binding consensus 
sequence were placed upstream of the SV40 basal promoter, and 0.5-kb of downstream 
sequence of the Hes1 gene was placed downstream of Ub-luc.  
 In the pCNP-Venus construct, gap-Venus-T2A-Venus coding sequence was 
subcloned into the CNP expression cassette, which has a 3.9-kb fragment of the promoter 
region of CNP (2',3'-Cyclic-nucleotide 3'-phosphodiesterase) gene, and poly-adenylation 
sequence of SV40. The detailed cloning strategy and complete sequence of the plasmids 
are available on request. 
 
Animals   
 All animals were handled in accordance with the Kyoto University ‘Guide for the 
Care and Use of Laboratory Animals’. Time-pregnant females were maintained in a 12 hr 
light/dark cycle and obtained by overnight breeding with males of the same strain. Noon 
following breeding is considered as E0.5. Rosa26-LoxP-Stop-LoxP-NICD (40), DCX-
DsRed (41), pCAG-mAG-hGem(1/110) (42), and pCAG-mKO2-hCdt1(30/120) (42) 
lines were described previously. Transgenic (Tg) or knock-in reporter strains were 
generated as described below. 
 
Conventional Tg mice  
 To prepare the DNA fragments for pronuclear injection, the vector backbone 
sequences were removed. The constructs were isolated by agarose gel electrophoresis, 
purified with QIAEX II (Qiagen) and injected into the pronuclei of fertilized one-cell 
eggs from ICR mice. Typically 200-300 fertilized eggs were injected. Genotypes were 





BAC Tg mice  
 BAC targeting was conducted using BAC recombineering (43,44). BAC clones 
were selected from the Ensembl database (http://www.ensembl.org), and obtained from 
the BACPAC Resources Center at Children’s Hospital Oakland Research Institute 
(CHORI). BAC DNA was transferred from DH10B strain to SW105 strain by 
electroporation. The identity and integrity of these BAC clones were verified by a panel 
of PCR primers and restriction digestions. For generating N-terminal reporter-fusion 
BAC Tg constructs, reporter coding sequences without stop codon were amplified by 
PCR, and cloned into pBluescript II SK+ plasmid. HA and flag epitope tags were 
attached to the N-terminus of Luc2 and Venus, respectively. In front of the reporter 
coding sequences, frt-PGK-EM7-Neo-frt cassette was inserted. The Neo gene is driven 
by both the PGK promoter for G418 selection in ES cells and the EM7 promoter for Kan 
selection in Escherichia coli. A BAC targeting vector was generated for each gene by 
cloning 300-500-bp homology arms from the gene into a reporter plasmid, flanking the 
frt-Neo-frt-reporter cassette. For recombineering, BAC targeting cassettes were excised 
by restriction digestion, and electroporated into competent SW105 cells containing the 
BAC clone of interest. Targeted BAC clones were selected for KanR, and correctly 
targeted BAC clones were identified by a panel of PCR primers and restriction digestions. 
frt-Neo-frt selection cassette was removed by arabinose-mediated transient FLP 
recombinase expression in SW105 (43,44). BAC DNA was purified with a NucleoBond 
Xtra Midi kit (Macherey-Nagel) and injected into the pronuclei of fertilized one-cell eggs 
from ICR mice. Typically 300-400 fertilized eggs were injected. Potential founder 
animals were screened by PCR of tail DNA. Founder lines having a single copy of BAC 
transgene were selected by real-time PCR and used for subsequent analysis. 
 
Knock-in mice 
 Generation of N-terminal reporter-fusion knock-in constructs was conducted using 
BAC recombineering. We used the pMCS-DTA retrieval vector (Gift from Dr. Kosuke 
Yusa, Osaka University, Japan) as the backbone of our knock-in vectors. pMCS-DTA 
contains the diphtheria toxin fragment-A (DTA) gene driven by the MC1 promoter for 
negative selection in ES cells. Knock-in cassette fragments were retrieved from modified 
BAC clones into pMCS-DTA by recombineering. BAC targeting was performed 
similarly to that of transgene construction of BAC Tg mice as described above. The first 
exon and the initial part of the first intron sequences were inserted between reporter 
(Venus or ELuc) coding sequence and the frt-PGK-EM7-Neo-frt cassette, so that frt-
PGK-EM7-Neo-frt was inserted into the first intron region. A BAC targeting vector was 
generated for each gene by cloning 300-500-bp homology arms from the gene into a 
reporter plasmid. Targeted BAC clones were selected for KanR, and confirmed by a 
panel of PCR primers and restriction digestions. A correctly targeted BAC clone was 
used for generating the knock-in construct by the BAC retrieval method (43). The 5'- and 
3'-homology arms in the retrieval vector were designed such that between 3- and 8-kb 




were subcloned into pMCS-DTA. The total length of homology (3- and 8-kb on either 
side) was sufficient for gene targeting in ES cells (TT2). The shorter homology arm was 
used to design PCR-based screening for targeted ES cells. Southern blot hybridization 
was performed to confirm successful homologous recombination. Chimeric mice were 
produced from successfully targeted ES cell clones by aggregation with ICR embryos. 
Germ line transmission of the targeted allele was assessed by PCR of tail DNA.  
 
Monolayer neural progenitor cell (NPC) culture  
 NPC culture was prepared and maintained using NS cell culture method, as 
described previously (30). Basal forebrain regions, including the medial, lateral and 
caudal ganglionic eminences, were excised from perinatal mice, and digested with Papain 
(Worthington) for 20 min at 37°C and dissociated completely by pipetting. Papain 
inhibitor was added, and then the cells were spun down, and resuspended in serum-free 
culture medium (NS-A media (Euroclone) plus N2 supplement (R&D Systems), 10 ng/ml 
of both basic FGF and EGF (Invitrogen), and penicillin/streptomycin). Culture dishes 
were coated with poly-L-ornithine (Sigma) and fibronectin (R&D Systems). In this study, 
acutely dissociated NPCs or established NS cells (at least 10 passages and 1 
cryopreservation) were used. Detailed protocols for routine handling of NS cells were 
previously described (30). 
 
Neuronal, astrocyte and oligodendrocyte differentiation of NPCs  
 Differentiation of NS cells was induced as described previously (30). For neuronal 
differentiation, NS cells were harvested using Papain to detach cells and 0.5-1.0 x 104 
cells were re-plated into a poly-L-ornithine/fibronectin coated 35 mm dish in NS-A 
medium supplemented with 0.5µM retinoic acid (Sigma), N2, and B27 supplement. 
Rapid differentiation of NS cells to GFAP-positive astrocytes occurred within 2 days of 
exposure of NS cells to 80 ng/ml LIF (Millipore) and 80ng/ml BMP4 (R&D Systems). 
For oligodendrocyte differentiation, NS cells were harvested using Papain to detach cells 
and 0.5-1.0 x 104 cells were re-plated into a poly-L-ornithine/fibronectin coated 35-mm 
dish in NS-A medium supplemented with N2, 10ng/ml PDGF (R&D Systems) and 
30ng/ml 3,3,5-triiodothyronine (T3; Sigma). 
 
NPC transfection  
 NS cells were nucleofected using an AAD-1001 nucleofector device with mouse 
NS cell nucleofector solution (Amaxa), program A-033, and 5 µg of DNA per 1.0 x 106 
cells. Cells were analyzed 48 hr after nucleofection. 
 
Lentiviral vector production and transduction of NPCs   
 Coding sequences of gene of interest were inserted into multiple cloning sites of 
CSII-EF-MCS (45). Lentiviral particles were produced via calcium phosphate 
cotransfection of 293T cells with the packaging plasmids in the same procedure as 
previously described (45). Supernatants were collected starting from 24 hr after the 




resulting viral pellet was resuspended in PBS at 1/500th of the original volume, and the 
viral aliquot was then frozen. Viral titers were approximately 109 infectious units/ml. 
Cultured NS cells were infected by purified lentiviral particles with MOI = 
approximately 10-20, and analyzed 48 hr after infection. 
 
Immunocytochemistry  
 Cells were washed by phosphate-buffered saline (PBS) and fixed with 4% 
paraformaldehyde (PFA)/PBS for 20 min at room temperature. Fixed cells were washed 
by PBS, then blocked and permeated with 5% normal donkey serum (NDS) and 0.1% 
Triton X-100/PBS at room temperature for 20 min, incubated with primary antibodies 
diluted in PBS containing 1% NDS overnight at 4°C, washed with PBS, and then 
incubated with regular secondary antibodies conjugated to Alexa 488, Alexa 594 or 
Alexa 647 (1:200, Invitrogen) for 1 hr at room temperature. Stained cells were 
photographed with LSM510 or LSM780 confocal microscopes (Zeiss). 
 
Immunohistochemistry  
 Embryos were fixed in 4% PFA/PBS for 3 hr or overnight at 4°C, washed in ice-
cold PBS, equilibrated in 20% sucrose/PBS at 4°C, embedded in OCT compound (Sakura 
Finetek), and frozen at –80°C. Pups and adult mice were deeply anesthetized and 
perfused transcardially with 30 ml of PBS and 30 ml of 4% PFA/PBS. Brains were 
postfixed in the perfusing solution overnight at 4°C and then cryoprotected for 48 hr in 
20% sucrose in PBS. Brains were embedded in OCT compound, and frozen at –80°C. 
Sections were made at 16-µm thickness using a cryostat, and incubated in 5% NDS and 
0.1% Triton X-100/PBS at room temperature for 1 hr, and with primary antibodies 
diluted in 0.1% Triton X-100/PBS containing 1% NDS overnight at 4°C. Sections were 
washed with PBS, and incubated with secondary antibodies conjugated to Alexa 488, 
Alexa 594 or Alexa 647 (1:200, Invitrogen) for 2 hr at room temperature. Then, sections 
were mounted with Fluormount-G (Southern Biotech) and photographed with LSM510 or 
LSM780 confocal microscope (Zeiss). Immunostaining for NICD was done, as 
previously described (46). 
 
Antibodies  
 The following primary antibodies (final dilution for immunohistochemistry and 
source) were used: rabbit anti-GFP (1:500; Invitrogen A11122), rat anti-GFP (1:200; 
Nacalai tesque GF090R), rabbit anti-DsRed (1:500; Clontech 632496), rat anti-HA 
(1:200; Roche 3F10 clone), rabbit anti-βIII-Tubulin (1:500; Covance A11122), mouse 
anti-βIII-Tubulin (1:500; Covance MMS-435P), rabbit anti-GFAP (1:500; DAKO 
Z033429), mouse anti-GFAP (1:500; Sigma G3893), rabbit anti-CNPase (1:500; CST 
5664S), mouse anti-Nestin (1:500; BD Pharmingen 556309), rabbit anti-PH3 (1:500; 
Millipore 06-570), rabbit anti-Hes1 (1:500), guinea pig anti-Hes1 (1:500), mouse anti-
Ascl1 (1:500; BD Pharmingen 556604), rabbit anti-Olig2 (1:500; IBL 18953), mouse 
anti-Olig2 (1:500; Millipore MABN50), rabbit anti-Sox2 (1:500; Millipore AB5603), and 





RNA in situ hybridization 
  RNA in situ hybridization was performed using digoxigenin-labeled Luc2 and Eluc 
antisense RNA probes, as described previously (47). 
 
Fluorescence-activated cell sorting (FACS)  
 NPCs were dissociated with Papain (Worthington), washed with DMEM/F12 
supplemented with N2 supplement (R&D Systems) and 0.1% BSA, and collected by 
centrifugation. Large clumps of cells were removed using a cell strainer (BD 
Biosciences). Cells were sorted and analyzed on a flow cytometer (ARIA II; BD 
Biosciences). The fluorescence activities of Venus and mCherry were detected in the 
FITC (Ex = 488nm) and Grn PE (Ex = 561nm) channel, respectively. NPCs were sorted 
to DMEM/F12 supplemented with N2 supplement (R&D Systems) and 0.1% BSA, and 
collected by centrifugation. For differentiation assays, NPCs were directly sorted to 
serum-containing differentiation medium; DMEM/F12 supplemented with N2 
supplement (R&D Systems), B27 supplement (Invitrogen), 10% fetal bovine serum and 
penicillin/streptomycin.  
 
Neurosphere assay  
 Neurosphere assays were performed from FACS-purified NPCs as described 
previously (48). Cells sorted by FACS were collected by centrifugation and re-suspended 
in neurosphere medium (N2 supplement (R&D Systems), B27 supplement (Invitrogen), 
20ng/ml of EGF (Invitrogen) and 20ng/ml of bFGF (Invitrogen), and 
penicillin/streptomycin). Cells were counted and plated in uncoated 35-mm dishes 
(50,000 cells per dish). Primary neurospheres were counted 7 days after plating, and 
neurospheres were passaged by harvesting them by centrifugation (200g for 5 min) and 
triturating them in 100µl of medium with an automatic pipetter (P200 Gilson).  
 
Differentiation assay  
 Cells sorted by FACS were collected by centrifugation and re-suspended in serum-
containing differentiation medium, and then seeded in poly-L-ornithine- and fibronectin-
coated 35-mm dishes (50,000 cells per dish). After 7 days in culture, cells were fixed and 
analyzed by immunocytochemistry. Data are presented as mean ± SEM from at least n=6 
independent experiments counting >200 cells from randomly selected fields per each 
experiment.   
 
Luminescence imaging of NPCs  
 NPCs carrying reporters were plated to coated 35-mm glass-base dishes at 50-60% 
confluence and incubated at 37°C and 5%CO2. Cells were imaged just after plating or 
next day. 1mM luciferin was added to the culture medium. Bioluminescence images were 
acquired by an upright microscope (IX81; Olympus) with x60 dipping objective (1.42 
NA). Digital images were acquired using a cooled CCD camera (iKon-M DU934P-BV, 




Morph; Universal Imaging Corp.). Stray light was cut off by turning off the electric 
system. The imaging system was used in a dark room. For dual-color bioluminescence 
imaging, we used only bandpass emission filters (FF01-510/84-25 for Eluc and BLP01-
635R-25 for Red luc, Semrock). Luciferase-reporter mice were crossed with DCX-DsRed 
(41) Tg mice for monitoring neuronal differentiation or with pCNP-Venus mice for 
monitoring oligodendrocyte differentiation, and NPCs were collected from the double Tg 
mice. To monitor the cell cycle phases, luciferase-reporter mice were crossed with 
pCAG-mAG-hGem(1/110) (42) & pCAG-mKO2-hCdt1(30/120) (42) mice, and NPCs 
were collected from the triple Tg mice. 
 
Organotypic slice culture for luminescence imaging  
 Time-lapse imaging of brain slices was performed, as described previously (49). 
Embryos were harvested in PBS, and brains were isolated in DMEM/F-12 supplied with 
10mM HEPES.  Brain tissue was immediately transferred into a silicon rubber-coated 
dish with DMEM/F-12 containing 10mM HEPES, which was previously bubbled with 
100% O2 for 10–15 min on ice. Meninges were removed, and coronal brain slices (100–
200-µm thickness) were manually prepared by ophthalmic microsurgical knife (Alcon). 
Slices of basal telencephalon were transferred to a glass-base dish containing slice culture 
medium (DMEM/F-12 supplemented with N2, B27, 20ng/ml EGF, 20ng/ml bFGF, 5% 
horse serum, and 5% fetal bovine serum). Slices were immersed in about 200µl of type Ia 
collagen (Cellmatrix, Nitta Gelatin) (diluted to 1.5mg/ml with DMEM/F-12 and 
neutralizing buffer according to the manufacturer’s instructions and kept on ice until use) 
at room temperature. After 20-min incubation at 37°C, slices were cultured at 37°C in 
1ml of slice culture medium containing 1mM luciferin. Then, the dish was placed on a 
stage of inverted microscope and maintained at 37°C in 5% CO2 and 45% O2. 
Bioluminescence from the sample was acquired using the CCD camera, as described 
above. 
 
Fluorescence imaging of NPCs  
 Fluorescent live cell images were acquired using a confocal laser scanning 
microscope, LSM 780 (Carl Zeiss), equipped with the spectral GaAsP array detector. 
NPCs were plated to coated 35-mm glass-base dishes at 50-60% confluence and 
incubated at 37°C and 5% CO2. Venus and mCherry fluorescent protein were activated 
by 514-nm Argon laser and 561-nm DPSS laser, respectively. Images were acquired with 
the photon-counting mode. Spectral imaging was performed using a 32-channel GaAsP 
detector of the LSM 780 system, and specific Venus or mCherry fluorescent signal was 
separated from autofluorescence by applying linear unmixing algorithms (Carl Zeiss). 
 
Image analysis and quantification  
 Image analysis was performed using ImageJ software and custom plug-ins. Custom 
written code of ImageJ plug-ins used in this study is available on request. 
 For analyzing an image sequence file of bioluminescence imaging, ‘Spike-noise 




readout noise was also removed by ‘Temporal background reduction filter’. In this 
normalization procedure, the background value measured in the outside of the imaging 
regions for each time-flame was subtracted from the signal intensity. Tracking individual 
cells and quantification of bioluminescence signals were conducted with ‘Circadian Gene 
Expression (CGE)’ (http://bigwww.epfl.ch/sage/soft/circadian/). In some experiments, 
nuclear localized mCherry was expressed by nucleofection or lentivirus vectors, and used 
to detect and track moving cells. Average signal intensity inside the nucleus were 
measured, illustrated and analyzed by Prism 5.0 software (GraphPad Software).  
 Fixed monolayer NPCs were immunostained, and images were acquired with a 
Zeiss Axio Observer.Z1 inverted microscope with a 20x Plan-Apochromat objective (0.8 
NA) or 40x Plan-Apochromat objective (1.3 NA). Automated segmentation was 
performed, and data was analyzed using custom written code (Static particle analyzer) in 
ImageJ. Histogram and scatter plot of protein levels in single cells were illustrated and 
analyzed by Prism 5.0 software.  
 
Ascl1 expression by light-switchable gene expression system  
 Codon-optimized GAVPO (36) (blue light-activatable Gal4 transcriptional activator, 
hGAVPO) was subcloned into pEF-BOS expression vector for ex utero electroporation 
and CSII-EF-MCS-IRES2-Bsd plasmid (45) for lentivirus production. Bsd is the 
resistance for blasticidin. CSII-EF-MCS was digested with AgeI to remove EF promoter, 
and 5x UAS sequence and 3’-untranslated region (UTR) of mouse Ascl1 gene was cloned 
in the opposite orientation to the LTR-mediated transcription. NLS-Ub-luc2 or Ascl1 
coding sequences were inserted immediately after the 5x UAS sequence.    
 Using the CSII-EF-hGAVPO-IRES2-Bsd, CSII-UAS-NLS-Ub-luc2 or CSII-UAS-
Ascl1 plasmids, lentiviral particles were produced and purified as described above. 
Established wild-type or Ascl1-mutant NS cells were co-infected with EF-hGAVPO-
IRES2-Bsd&UAS-NLS-Ub-luc2 or EF-hGAVPO-IRES2-Bsd&UAS-Ascl1 lentiviral 
particles, and blasticidin S (20µg/ml; Invitrogen)-resistant cells were selected. 
Blasticidin-selected cells were passaged 3- to 5-times before analysis. 
 For generating oscillatory expression of transgene, blue-light was illuminated for 1 
min with a 3-hr interval. For achieving sustained expression of transgene, blue-light was 
illuminated for 2 min with a 30-min interval, unless otherwise noted.  Blue light was 
generated by pE-2 LED excitation system (CoolLED) equipped with 470-nm LAM and 
illuminated to cells through the x40 objective lens (UPLFLN40XO). Light-intensity was 
adjusted to 1 to 7%. Measured light power (LED = 1%) was approximately 200µmol/m2/s 
in this experimental condition. Blue-light illumination was automatically controlled using 
Meta Morph software. In the analysis of cell-proliferation or differentiation analysis, 
blue-light was generated by LEDB-SBOXH (OptoCode) in CO2-incubators. Light power 
was changed from 0.16µmol/m2/s to 1.11µmol/m2/s. To analyze the effects of oscillatory 
or sustained expression on cell proliferation and neuronal differentiation, plated NPCs 
were illuminated for 72 hr and analyzed by immunocytochemistry. Data are presented as 
mean ± SEM from at least n=3 independent experiments counting >200 cells from 




 Ascl1-light inducible system was introduced into dorsal telencephalon progenitors. 
pEF-mCherry-NLS, pEF-hGAVPO and CSII-UAS-NLS-Ub-luc2/CSII-UAS-Ascl1 
plasmids were mixed at 2:3:5 ratio, and co-transfected into E14.5 dorsal telencephalon 
progenitors by ex utero electroporation. Plasmid DNA (2.5µg/µl) was microinjected into 
a telencephalic ventricle, and ex utero electroporation (5 pulses, 50mV, square wave 
generator (CUY21, BEX), 5-mm paddle electrodes) was performed for transfection of 
plasmids into progenitors at the ventricular surface of the neocortex. Brains were 
immediately dissected, embedded in 3% low-melting point agarose, cut into 250-µm 
organotypic slices with a vibratome (VT1000; Leica), transferred to 35-mm well culture 
insert (353090, BD Falcon), and cultured in slice culture medium. Slices were incubated 
at 37°C, 5%CO2 under the periodic blue-light illumination. For analyzing cell fate 
specification of transfected NPCs, electroporated hemispheres were immediately 
dissociated by Papain and plated to coated 35-mm glass-base dishes at 50-60% 
confluence, and incubated at 37°C and 5% CO2. 
 
Statistical Analysis  
 Statistical analyses were performed with Prism 5.0 software (GraphPad). P values 
less than 0.05 were considered to be significant. Statistical methods used in the analysis 





Hes1 represses the expression of itself and Dll1 (a ligand for Notch signaling) of the same cell,
while Hes1 expression is up-regulated by Dll1 of the neighboring cells (Fig. 1). We show through
a simple mathematical model that this regulatory pathway generates oscillation and suppression of














Dj(t) (two-cell model, j = i)∑
j =i,|rj(t)−ri(t)|<I Dj(t) (multicell model).
(3)
Here, i, j are the labels for cells, which are 1 or 2 in the two-cell model, and 1 ≤ i, j ≤ N in the
multicell model. Hi(t) and Di(t) are the protein level of Hes1 and Dll1 in cell i, respectively. VH and
VD are the maximum synthesis rates, and dH and dD are the degradation rates of the corresponding
proteins. τH in Eq. (1) is the time required for Hes1 to affect its own formation in the same cell
through the negative feedback loop (50 ). D〈i〉(t) is the total Dll1 input that cell i receives at time
t from neighboring cells. In the multicell model, the two-dimensional position of cell i at time t is
denoted as ri(t) = (xi(t), yi(t)), and the sum in Eq. (3) is taken over the cells that are in the positions
close enough to cell i (length= |rj − ri| < I). KHD,KH and KDH correspond to the typical amount
of Hes1 or Dll1 that account for the enhancement or repression. Although it is more realistic to
introduce time delays to D〈i〉(t) in Eq. (1) and Hi(t) in Eq. (2), we have confirmed that the basic
features of the model remain the same in the absence of such time delays when dD  dH. We set all
Fig. 1: Schematic structure for the Hes1 and Dll1 regulatory pathway. Hi and Di correspond to
the protein level of Hes1 and Dll1 in cell i, respectively. Cells interact through the Notch signaling
activation induced by Dll1.
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the Hill coefficients to be 2, following the notion that Hes1 and Dll1 act as dimers. Assuming larger
Hill coefficients does not change the qualitative dynamics.
Fig. 2: Numerical simulation of the two-cell model given by Eqs. (1,2). Lines show the time series of
protein levels (arbitrary units) after transient time. The Hes1 protein level of one of the cells shows
a clear oscillatory behavior with period ∼2.7h, whereas in the other cell it becomes almost quiescent.
This behavior is reproduced for any given random initial condition. We used the parameter values
τH = 1[h], dH = 2.1[h
−1] (both estimatied from experiments), dD = 1.5[h−1], VH = 50, V = 5,
KHD = 1,KH = 1.5, and KDH = 0.1.
First, we show the result for the two-cell case (Fig. 2). Although the equations (1) and (2) are
symmetric in i = 1, 2, the average level of Hes1 takes two discrete values in the two cells. This is
due to the mutual (lateral) inhibition effect of Dll1 through Hes1, and whether cell 1 or 2 keeps the
higher Hes1 level is determined by the randomly given initial condition. In Fig. 2, the high Dll1
level in cell 2 activates Notch signaling in cell 1, yielding the high, oscillatory Hes1 expression in cell
1. Such self-sustained oscillation occurs in a delayed feedback model in the condition that Hi(t) is
sufficiently expressed (51 ). Dll1 expression in cell 1 is suppressed by the high Hes1 expression, and
consequently the Notch signaling level in cell 2 is insufficient to produce abundant Hes1.
Next, we construct the multicell model. Considering that neural progenitor cells move slowly
in vivo, we artificially model the motion of each cell by an overdamped Brownian motion in the two-
dimensional space. We further assume an attracting force between cells, modeled by a linear elastic
force with the natural length L and stiffness k, to incorporate the fact that cells do not disperse
in vivo. The equation of motion is given by,
˙ri(t) = − ∂
∂ri
U(r1, r2, ...rN ) + ξi(t), (4)





k(|ri(t)− rj(t)| − L)2, (5)
where U(r1, r2, ...rN ) is the “potential” that mimics the motional interaction between the cells. The
potential confines the neighbor cells at a typical distance L, which should serve as a model for cell
adhesion. The cutoff length C is introduced since cell adhesion occurs only between neighboring




i (t)) is the noise, satisfying 〈ξxi (t)ξxj (s)〉 = 〈ξyi (t)ξyj (s)〉 = Aδijδ(t − s) and
〈ξxi (t)ξyj (s)〉 = 0, with 〈 〉 being the ensemble average. Simulation of this multicell model including
cell division (method shown in the caption of Fig. 3) expresses the feature that the random motion
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Fig. 3: Numerical simulation of the multicell model [Eqs. (1,2) and Eq. (4)]. We used the same
parameter values as those in Fig. 2 for Eqs. (1,2), except for KHD. We set KHD = 1, since the cells
typically interact with 6 neighbor cells in our multicell model. For the motion of the cells [Eq. (4)],
we used the parameters L = 1 (unit of cell size), I = C = 1.25, A = 0.04, and k = 8. We initially
prepared N = 60 cells, and assumed that the cells undergo cell division every 24h (thus N increases
with time). In the event of the division, the Hes1 and Dll1 values were equally shared between the
two daughter cells. The initial positions of the cells were given randomly in a relatively small region.
a) Snapshot of the cell position and Hes1 level (color scale) in the simulation. The typical interval
between the center of cells (depicted by the circle with diameter 0.5) is approximately L(= 1) due
to the motional interaction [Eq. (5)]. The green color scale corresponds to the relative level of Hi(t)
(Hes1); green cells are mostly oscillating, whereas the black cells are in the quiescent phase (low Hes1
and high Dll1 level). b) The typical time courses of Hes1 level in 4 cells in the multicell simulation.
Some cells are in the oscillatory phase (cell 1), whereas others stay in the quiescent phase (cell 4).
Because the random motion and cell division provide relatively strong perturbation to the cells, some
cells experience both the Hes1 oscillatory and quiescent phases during the time course (cells 2 and
3). Cells that are stuck in the quiescent phase may express Ascl1 in a sustained manner, and later
differentiate into neurons.
as well as the proliferation of the cells allow single cells to switch back and forth between the Hes1
positive and negative phases (cells 2 and 3 in Fig. 3b), corresponding to the two phases observed in






Fig. S1. Reporter-fusion BAC Tg constructs for monitoring protein expression 
dynamics of transcription factors. 
(A) Luc2-Hes1 fusion BAC Tg mouse. (B) Luc2-Ascl1 fusion BAC Tg mouse. (C) 
Venus-Ascl1 fusion BAC Tg mouse. (D) Luc2-Olig2 fusion BAC Tg mouse. (E) 
mCherry-Olig2 fusion BAC Tg mouse. (F) Venus-Olig2 fusion BAC Tg mouse. (G) 
Luc2-Sox2 fusion BAC Tg mouse. Coding region is shown in grey. More detailed 






Fig. S2. Reporter-fusion knock-in strategy for monitoring expression dynamics of 
Hes1 and Hes5 proteins. 
(A) Venus-Hes1 fusion knock-in mouse. (B) Venus-Hes5 fusion knock-in mouse. (C) 
ELuc-Hes5 fusion knock-in mouse. Closed box indicates coding region. More detailed 





Fig. S3. Faithful reporter expression in the reporter mice. 
(A-D) In situ hybridization for Luc2 (A-C) and Eluc (D) mRNA of luciferase-reporter 
mice at E12.5. Coronal sections of the brains of Luc2-Hes1 fusion BAC Tg mouse (A), 
pHes5-NLS-Ub-Luc2-Tg mouse (B), Luc2-Ascl1 fusion BAC Tg mouse (C) and ELuc-
Hes5 fusion knock-in mouse (D). (E-J) Immunofluorescence for Venus (E-I) or mCherry 
(J) of coronal sections of Venus-Hes1 fusion knock-in mouse (F,F), Venus-Hes5 fusion 
knock-in mouse (G), Venus-Ascl1 fusion BAC Tg mouse (H), Venus-Olig2 fusion BAC 
Tg mouse (I), and mCherry-Olig2 fusion BAC Tg mouse (J). Double immunolabelling 





Fig. S4. Correlation between reporter and endogenous protein expression. 
NPC cultures were prepared from reporter-fusion Tg or knock-in mice. (A-G) 
Representative images of immunocytochemistry indicating well-correlated reporter 
protein expression to endogenous protein expression. (H) Scatter plot of Hes1 protein 
levels versus HA-Luc2-Hes1 fusion protein levels. Each point represents Hes1 protein 
and HA-Luc2-Hes1 fusion protein signals in a single cell. (I) Ascl1 versus HA-Luc2-
Ascl1. (J) Olig2 versus HA-Luc2-Olig2. (K) Sox2 versus HA-Luc2-Sox2. (L) Hes1 
versus Venus-Hes1. (M) Ascl1 versus Venus-Ascl1. (N) Olig2 versus mCherry-Olig2. 
Luciferase and fluorescent reporter expression correlated very well with endogenous 






Fig. S5. Normal brain development of the reporter mice and their normal 
differentiation competency of NS cells.  
(A-E’) HE staining of the coronal sections of the adult brain from wild-type (A,A’), 
homozygous Venus-Hes1 fusion knock-in (B,B’), heterozygous Luc2-Hes1 fusion BAC 
Tg (C,C’), heterozygous Luc2-Ascl1 fusion BAC Tg (D,D’), heterozygous Luc2-Olig2 
fusion BAC Tg (E,E’) mice. The dorsolateral region of the subventricular zone of the 
lateral ventricle is enlarged in (A’-E’). (F-H) NS cells were generated from wild-type, 
homozygous Venus-Hes1 fusion knock-in, heterozygous Luc2-Hes1 fusion BAC Tg, 
heterozygous Luc2-Ascl1 fusion BAC Tg, and heterozygous Luc2-Olig2 fusion BAC Tg 
mice. These NS cells were transferred to a differentiation medium containing serum, and 
analyzed 7 days later by immunocytochemistry. Their competency to generate neurons, 
astrocytes, and oligodendrocytes was not distinguishable between all genotypes. ns: not 






Fig. S6. Variable expression levels of bHLH factors in self-renewing NPCs. 
(A-D) Proliferating NPCs were immunostained with anti-Sox2 (A), anti-Hes1 (B), anti-
Ascl1 (C), and anti-Olig2 (D) antibodies. Hes1, Ascl1, and Olig2 expression levels were 
variable while another NPC-specific factor, Sox2, was expressed at a relatively constant 
level. (E-I) Histograms of mean normalized Sox2, Hes1, Venus-Hes5, Ascl1, and Olig2 
staining intensity in proliferating NPCs. (J) Comparison of the standard deviations of the 
expression levels. The variability of Sox2 expression was very small compared to the 








Fig. S7. Abnormal differentiation competency of NS cells mutant for bHLH factors. 
NS cells were generated from wild type (A-A’’’), Hes1-KO (B-B’’’), Ascl1-KO (C-C’’’), 
and Olig2-KO (D-D’’’) mice. These NS cells were immunostained with anti-Nestin (NPC 
marker), anti-βIII-tubulin (neuron marker), anti-GFAP (astrocyte marker), and anti-
CNPase (oligodendrocyte marker) antibodies. 15% of Hes1-KO cells expressed βIII-
tubulin, and 5.5% of Ascl1-KO cells and 53% of Olig2-KO cells displayed GFAP 
expression before induction of differentiation. (E-K) These NS cells were transferred to a 
differentiation medium containing serum, and analyzed 7 days later by 
immunocytochemistry. Their competency to generate neurons, astrocytes, and 
oligodendrocytes was significantly reduced in the absence of Ascl1, Hes1, and Olig2, 
respectively. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA 





Fig. S8. Oscillatory expression of Hes1 protein in NPCs. 
NPC cultures were prepared from Luc2-Hes1 fusion BAC Tg mice (A,B) or Venus-Hes1 
fusion knock-in mice (C,D). (A,B) Bioluminescence images and quantification of Luc2-
Hes1 fusion protein dynamics in self-renewing NPCs. (C,D) Quantification of Venus-





Fig. S9. Oscillatory expression of Hes5 protein in NPCs. 
NPC cultures were prepared from Eluc-Hes5 fusion knock-in mice (A) or Venus-Hes5 
fusion knock-in mice (B). (A) Quantification of ELuc-Hes5 fusion protein dynamics in 
self-renewing NPCs. (B) Quantification of Venus-Hes5 fusion protein dynamics in self-
renewing NPCs. (C,G) Representative images of immunocytochemistry, and scatter plot 
of Hes1 protein levels versus Venus-Hes5 fusion protein levels. Each point represents 
Hes1 protein and Venus-Hes5 fusion protein signals in a single cell. (D,H) Sox2 versus 





Fig. S10. Oscillatory expression of the Hes5 promoter activity in NPCs. 
(A) The structure of pHes5-NLS-Ub-luc2 that monitors the Hes5 promoter activity. (B,C) 
NPC cultures were prepared from pHes5-NLS-Ub-luc2 Tg mice. Bioluminescence 
images and quantification of the Hes5 promoter activity in self-renewing NPCs. (D) 
Quantification of the Hes1 promoter and Hes5 promoter activity in a single cell. Hes1 
and Hes5 oscillations occurred in phase. (E) Reporter constructs for two-color 
simultaneous imaging of two promoter activities in single cells. These pHes1- and 






Fig. S11. Oscillatory expression of Ascl1 protein and promoter activity in NPCs. 
NPC cultures were prepared from Luc2-Ascl1 fusion BAC Tg mice (A-F), Venus-Ascl1 
fusion BAC Tg mice (G,H), and Ascl1-NLS-Ub-luc2 BAC Tg mice (I-K). (A-D) 
Bioluminescence images and quantification of Luc2-Ascl1 fusion protein dynamics in 
self-renewing NPCs. Cell cycle phase progression was monitored by the Fucci probe in 
Cell-3 (D). Bioluminescence images and quantification of the Luc2-Ascl1 fusion protein 
dynamics in Hes1-KO NPCs (E,F). (G,H) Quantification of Venus-Ascl1 fusion protein 
dynamics in self-renewing NPCs. (I-K) Transgenic construct of Ascl1-NLS-Ub-luc2 
BAC Tg mice (I). Bioluminescence images and quantification of the Ascl1 promoter 






Fig. S12. Oscillatory expression of Olig2 protein in NPCs. 
NPC cultures were prepared from Luc2-Olig2 fusion BAC Tg mice (A-C) and mCherry-
Olig2 fusion BAC Tg mice (D,E). (A-C) Bioluminescence images and quantification of 
Luc2-Olig2 fusion protein dynamics in self-renewing NPCs. Cell-cycle phase 
progression was monitored by the Fucci probe in Cell-3 (C). (D,E) Quantification of 






Fig. S13. Comparison of average expression levels of transcription factors in 
different cell-cycle phases of self-renewing NPCs. 
(A) Fucci probe that labels G1 phase nuclei in red and S/G2/M phase nuclei in green. 
NPC cultures were prepared from pCAG-mAG-hGem(1/110) and pCAG-mKO2-
hCdt1(30/120) double-transgenic mice. (B) Representative images of 
immunocytochemistry for analyzing expression levels of Hes1 with cell-cycle phase 
information in individual cells. (C-F) Comparison of average expression levels of Sox2 
(C), Hes1 (D), Ascl1 (E), and Olig2 (F) in different cell-cycle phases of self-renewing 
NPCs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA followed 





Fig. S14. Stable Sox2 protein expression and promoter activity of Nestin and Rosa26. 
(A-D) NPC cultures were prepared from Luc2-Sox2 fusion BAC Tg mice. Quantification 
of Luc2-Sox2 fusion protein dynamics in self-renewing NPCs. (E,G) Reporter constructs 
for imaging the Nestin and Rosa26 promoter activities. (F) Quantification of the Nestin 
promoter activity in NPCs. (H) Quantification of the Rosa26 promoter activity in NPCs. 






Fig. S15. Correlation between bHLH protein expression in self-renewing NPCs. 
(A-C) Representative images of immunocytochemistry of NPCs. (D) Scatter plot of 
Ascl1 protein levels versus Venus-Hes1 fusion protein levels. Each point represents 
Ascl1 protein and Venus-Hes1 fusion protein signals in a single cell. (E) Olig2 versus 









Fig. S16. FACS analysis of variable expression levels of bHLH factors in self-
renewing NPCs. 
NPC cultures were prepared from fluorescent reporter-fusion knock-in mice or BAC Tg 
mice; Venus-Hes1 (A,D,G,J,M,P), Venus-Ascl1 (B,E,H,K,N,Q), or mCherry-Olig2 
(C,F,I,L,O,R). (A-C) Expression levels and dynamics of bHLH factors were analyzed by 
FACS. Hes1, Ascl1, and Olig2 expression levels were variable. (D-L) Venus- or 
mCherry-low cells (the lowest 10% of the whole population) and Venus- or mCherrry-
high cells (the highest 10% of the whole population) were sorted and re-analyzed 2 days 
later. These populations returned to the original distribution of expression levels within 2 
days when they were cultured in NS-cell culture medium. (M-R) Cells sorted by FACS 
were re-suspended in neurosphere medium, and plated in uncoated dishes. Primary 
neurospheres were counted 7 days after plating. Primary neurospheres were passaged and 
subjected to the secondary neurosphere assay. Hes1-high, Hes1-low, Ascl1-high, Ascl1-
low, Olig2-high and Olig2-low fractions generated neurospheres at similar efficiencies. 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA followed by 






Fig. S17. Different expression levels of bHLH factors bias the fate choice of NPCs. 
NPC cultures were prepared from fluorescent reporter-fusion knock-in mice or BAC Tg 
mice. (A-C) NPCs were separated by FACS into Hes1-high, Hes1-low, Ascl1-high, 
Ascl1-low, Olig2-high and Olig2-low fractions. After sorting, each cell population was 
immediately transferred to a differentiation medium, and analyzed 7 days later by 
immunocytochemistry. (D-G) NPC cultures derived from Venus-Ascl1 and mCherry-
Olig2 double Tg mice were subjected to FACS analysis. 5% of the total population 
depending on Ascl1 and Olig2 expression levels (Ascl1-high & Olig2-low, Ascl1-high & 
Olig2-high, Ascl1-low & Olig2-low, or Ascl1-low & Olig2-high) was sorted, and their 
differentiation competency was analyzed. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 






Fig. S18. Hes1 and Ascl1 expression dynamics during NPC division. 
(A) Temporal trajectories of Luc2-Hes1 just before NPC or neurogenic division at time = 
0 (mean in solid line and standard errors in colored, n > 30 for each division) were 
obtained by time-lapse analysis of NS cells derived from Luc2-Hes1 fusion BAC Tg 
mice (division-mode effect, p = 0.0016; interaction between division-mode and time, p < 
0.0001, repeated measures ANOVA). (B) The frequency of transient up-regulation (at 
least two-fold compared to the average) of Ascl1 expression before cell division. (C-F) 
Acute dissociation cultures were prepared from the ventral telencephalon of Luc2-Hes1 
fusion BAC Tg mice. Quantification of Luc2-Hes1 fusion protein dynamics during P-P 
(C,D) and N-N divisions (E,F). P-P, symmetric division that generates two NPCs; N-N, 






Fig. S19. Variable Notch signaling activities in NPCs. 
(A-G) NICD immunofluorescence was analyzed in embryonic brain sections (A-C) and 
cultured NPCs (D-G). NICD levels were lower near the apical side, where cells at the late 
G2 and early G1 phases were present. The boundary between VZ and SVZ was 
highlighted by white broken line. NICD expression levels were variable as that of bHLH 
factors in self-renewing NPCs (D-G). (H) Reporter construct for monitoring active 
NICD-RBPjk complex. (I) This reporter construct is not susceptible to Hes1/5 negative 
autoregulation because it does not contain Hes-binding sites, unlike the Hes promoters. 
Thus, the cellular activity of NICD-RBPjk complex can be faithfully monitored by this 
reporter. (J,K) The activity of NICD-RBPjk complex was dynamic in some NPCs (J), 
but was less dynamic in others (K). ****p < 0.0001, one-way ANOVA followed by 





Fig. S20. Stable oscillation of Hes5 expression in NPCs whose Notch signaling is 
constantly active. 
In NPCs, where NICD expression was constantly induced from the Rosa26 locus (A), 
oscillatory expression of Hes5 was dramatically stable (D,E,G, +Cre), compared with 
that in normal NPCs (B,C,F, −Cre). In normal NPCs, Hes5 oscillation is frequently 
disrupted (B,C, blue and orange asterisks). Variation of Hes5 oscillation periods in NPCs 






Fig. S21. Stable oscillation of Hes1 expression in NPCs whose Notch signaling is 
constantly active.  
In NPCs, where NICD expression was constantly induced from the Rosa26 locus (A), 
oscillatory expression of Hes1 was dramatically stable (B,C,D, +Cre), compared with 
that in normal NPCs (Fig. 2A,G,H). Variation of Hes1 oscillation periods in NPCs 






Fig. S22. Regulation of Ascl1 and Olig2 expression without Notch signaling. 
NPCs derived from Luc2-Ascl1 (A,B) and Luc2-Olig2 (C,D) were treated with DAPT 
(γ–secretase inhibitor). Ascl1 and Olig2 expression was up-regulated in a sustained 
manner after DAPT treatment. Quantification of the reporter expression at cell population 





Fig. S23. Expression dynamics of bHLH factors during astrocyte differentiation. 
(A) Astrocyte specification was induced at time = 0 by LIF and BMP4. GFAP expression 
was induced. (B,C) Quantification of Hes1 up-regulation during astrocyte differentiation. 
NPC, n=30; Astrocyte differentiation, n=21. Significance was analyzed by two-tailed 
Student’s t-test. (D-G) Quantification of Luc2-Ascl1 (D,E) and Luc2-Olig2 (F,G) 
expression during astrocyte differentiation. Quantification of the reporter expression at 








Fig. S24. Expression dynamics of bHLH factors during oligodendrocyte 
differentiation. 
(A,B) Quantification of Luc2-Olig2 (A) and pCNP-Venus expression (B) in a single cell 
during oligodendrocyte differentiation, which was induced at time = 0 by T3. (C,D) 
Quantification of Luc2-Olig2 (C) and pCNP-Venus (D) expression in the same cells 
(Cell-2 and their daughter cells, Cell-2a and cell-2b) during oligodendrocyte 
differentiation, which was induced at time = 0 by T3. (E,F) Comparison of Olig2 
expression levels at trough (E) and peak (F) of oscillation between NPCs and OPCs 
(oligodendrocyte precursor cells). Olig2 expression level in OPCs was significantly 
higher at trough than that in NPCs. Significance was analyzed by two-tailed Student’s t-
test. (G) Temporal trajectories (n > 16 cells) of Luc2-Olig2 (mean in solid line and 
standard errors in colored) and pCNP-Venus (mean in solid line and standard errors in 
colored).  Time = 0 (asterisk) corresponds to time of rapid Olig2 down-regulation. (H-J) 






Fig. S25. Characterization of pCNP-Venus Tg mice. 
(A) Schematic illustration of pCNP-Venus Tg construct. (B-F) Venus expression (green) 
was analyzed and compared with endogeneous CNPase expression (red) in the adult brain 





Fig. S26. Experimental design for light-induced oscillatory/sustained expression of 
Ascl1 in NPCs.  
(A) Strategy for the light-induced gene expression using humanized GAVPO (hGAVPO). 
(B) The schedule of light exposure. Ascl1 expression was induced in Ascl1-null NPCs. 
Repeated exposure of blue light with 3-hr intervals generated oscillatory expression with 
a 3-hr period, while repeated exposure with 30-min intervals generated sustained 
expression (Fig. 5A-K). (C) The schedule of light exposure. Sustained Ascl1 expression 
was induced in NPCs for indicated time lengths (Fig. 5L-P). Light intensity: ++, 
1.11µmol/m2/s. (D-G) Ascl1 expression was induced in Ascl1-null NPCs according to the 
schedule of light exposure (fig. S26B) and examined at t = 250 min and 360 min in 




same as Fig. 5A-C). Representative images (D) and their quantitative data (E) of 
immunocytochemistry and western blot (F) and its quantitative data (G) are shown. 
Quantitative data (mean ± SEM) are expressed as fold-change over wild-type control. For 
western, Ascl1 protein levels were normalized using anti-tubulin. Here, the peak level of 
the light-induced Ascl1 oscillation and the level of the light-induced sustained Ascl1 
expression were 3 to 6-fold and ~8-fold higher, respectively, than the endogenous 
average level in WT NPCs (E,G). Peaks of endogenous Ascl1 expression are several-fold 
higher than the average level of NPCs (Fig. 3, fig. S11), and therefore these light-induced 
levels are comparable to the endogenous peak levels in NPCs and differentiating neurons. 







Fig. S27. Oscillatory Ascl1 expression with 6-hour period did not affect the 
proportion of dividing cells in Ascl1-null NPCs. 
(A) The schedule of light exposure. Oscillatory Ascl1 expression with 6-hr period was 
induced in Ascl1-null NPCs, which were cultured in the presence of bFGF and EGF. 
(B,C) Oscillatory Ascl1 expression with 6-hr period induced virtually no βIII tubulin+ 
neuron formation (B) and did not significantly increase the proportion of dividing cells 






Fig. S28. Sustained Ascl1 expression at lower levels induces neuronal differentiation 
in Ascl1-null NPCs.  
(A) Repeated exposure with 30-min intervals by 1% LED power achieved sustained 
expression at comparable expression levels with the peak levels of oscillatory expression 
generated by blue light exposure with 3-hr intervals by 7% LED power. (B) The schedule 




cultured in the presence of bFGF and EGF, a condition that inhibits neurogenesis. Light 
intensity: +, 0.16µmol/m2/s; ++, 1.11µmol/m2/s. (C-F) Oscillatory Ascl1 expression 
induced virtually no βIII tubulin+ neuron formation (C) but significantly increased the 
proportion of dividing cells (PH3+), compared to the control (Ub-luc2) (D). Sustained 
Ascl1 expression at lower levels significantly increased βIII tubulin+ neuron formation 
(E) but did not affect the proportion of dividing cells (PH3+), compared to the control 
(Ub-luc2) (F). Data sets used in (C,D) were the same as that of Fig. 5D,E. *, p < 0.05; **, 






Fig. S29. Light-induced oscillatory/sustained expression of Ascl1 in wild-type NPCs. 
According to the schedule of light exposure (A), oscillatory (B-I) and sustained (J-Q) 
Ascl1 expression was induced in wild-type NPCs, which were cultured in the presence of 
bFGF and EGF, a condition that inhibits neurogenesis. Oscillatory light stimulation of a 
3-hr period did not significantly affect the neurogenesis or proliferation of these cells (B-
I). By contrast, sustained Ascl1 expression for 72 hr significantly increased neuronal 
formation with some tendency to reduce the proportion of dividing cells (J-Q). Light 
intensity: +, 0.16µmol/m2/s; ++, 1.11µmol/m2/s. The proportion of dividing cells was 
measured by immunostaining with anti-PH3 antibody. Cells having punctated signals in 
the nuclei were included in the PH3-immunopositive fraction in this study. *p < 0.05, **p 





Fig. S30. Sustained Ascl1 expression at lower levels induces neuronal differentiation 
in wild-type NPCs.  
(A) 30-sec blue-light pulse with 30-min intervals achieved sustained expression at 
comparable expression levels with the peak levels of oscillatory expression generated by 
1-min blue-light pulse with 3-hr intervals. (B) The schedule of light exposure. Ascl1 
expression was induced in wild-type NPCs, which were cultured in the presence of bFGF 
and EGF. Light intensity: 1.11µmol/m2/s. (C-F) Oscillatory light stimulation with 3-hr 
period did not significantly affect the neurogenesis or proliferation of these cells (C,D). 
By contrast, sustained Ascl1 expression at low levels for 72 hr significantly increased 
βIII tubulin+ neuron formation (E) but did not affect the proportion of dividing cells 






Fig. S31. Light-induced oscillatory/sustained expression of Ascl1 in dorsal 
telencephalic NPCs. 
(A) The Ascl1-inducible system was introduced into the dorsal telencephalon, which 
normally expresses very low levels of Ascl1, by ex utero electroporation. Transfected 
brains were immediately sliced or dissociated, and cultured for 72 hr under the periodic 
blue-light illumination, and then analyzed by immunostaining. (B-J’) Representative 
images of cortical slices, indicating distribution of the transfection marker (red; NLS-
mCherry) and NPC marker (green, Nestin). The oscillatory expression of Ascl1 
maintained Nestin+ NPCs in the ventricular zone (E,E’), while the sustained expression 
of Ascl1 increased the number of cells that migrated into the IZ/CP (I,I’, asterisk), 
resembling well the results in which Ascl1 was over-expressed by constitutively active 
CAG promoter (J,J’). Light intensity = 1.11µmol/m2/s. (K-P’’) According to the 
schedule of light exposure, oscillatory (K,L) and sustained (M-P’’) Ascl1 expression was 




stimulation with 3-hr period did not significantly affect the neurogenesis or maintenance 
of NPCs (K,L). By contrast, sustained Ascl1 expression for 72 hr significantly induced 
premature neuronal formation (M-P’’). Light intensity: +, 0.16µmol/m2/s; ++, 
1.11µmol/m2/s. VZ, Ventricular zone; SVZ, Subventricular zone; IZ, Intermediate zone; 













































































































































3'-UTR This study 
RBRC 
06023 




Express SV40 (41) 
 









































18 Hes1-KO KO       (53) 
RBRC 
05979 
19 Ascl1-KO KO       (54)  
20 Olig2-KO KO       (55)  
 
Table S1. 




Captions for Movies 
 
Movie S1 
Luc2-Hes1 expression in slice culture of the ventral telencephalon. Time in hr and min is 
indicated. Related to Fig. 1. 
 
Movie S2 
Luc2-Hes1 expression in self-renewing NPCs. Time in hr and min is indicated. Related to 
Fig. 2 and fig. S8. 
 
Movie S3 
Luc2-Ascl1 expression in self-renewing NPCs. Time in hr and min is indicated. Related 
to Fig. 2 and fig. S11. 
 
Movie S4 
Luc2-Olig2 expression in self-renewing NPCs. Time in hr and min is indicated. Related 
to Fig. 2 and fig. S12. 
 
Movie S5 




Light-induced oscillatory/sustained gene expression in NPCs. Time in hr and min is 
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